Crescendo Biologics Appoints Matthew Roe as Chief Business Officer

Cambridge, UK.  22 June 2011 - Crescendo Biologics Limited (Crescendo) today announces the appointment of Matthew Roe as Chief Business Officer.  Matthew joins Crescendo from Genzyme Corporation where he was Senior Director, Business Development & Licensing.

During a 23-year careeer at Genzyme, Matthew was active in licensing, alliance management, acquisition, divestment, and sales and marketing, and saw the corporation develop from an entrepreneurial start-up to a leading multi-national biotechnology company.  He negotiated and managed multiple agreements for drug delivery technologies in the USA, Europe and Japan and was also a core team member on the divestment of Genzyme's Pharmaceuticals business.